Bacterial News and Research

RSS

Novel synthetic antibiotic effective against drug-resistant bacteria

A new antibiotic created by Harvard researchers overcomes antimicrobial resistance mechanisms that have rendered many modern drugs ineffective and are driving a global public health crisis.

15 Feb 2024

TB cases in England spike by 10.7% in 2023

Figures published today by the UK Health Security Agency (UKHSA) in its TB annual report, show that tuberculosis cases in England in 2022 were stable compared to 2021 (4,380 in 2022 compared to 4,411 in 2021).

15 Feb 2024

Study explores health benefits of selenium and zinc-enriched eggs

Researchers investigated the effect of a diet of selenium- and/or zinc-enriched eggs (SZE) on oxidative stress, cognitive impairment, and intestinal flora in D-galactose-induced aging mice.

15 Feb 2024

Twin study investigates the role of the microbiome as a modifier in mental disorders

Researchers examined whether the influence of gut microbiome perturbations on various biological processes, such as the dysregulation of the hypothalamic–pituitary–adrenal axis, performance of the immune system, and the production of neurotransmitters and short-chain fatty acids contributed to the manifestation and progression of mental health disorders such as anxiety, depression, and eating disorders.

15 Feb 2024

Oral bacteria interaction leads to smelly breath

Having bad breath really stinks! Now, researchers from Japan report that a particular combination of bacteria in our mouths may be responsible for producing some very unpleasant smells.

14 Feb 2024

How does intermittent fasting affect the gut microbiome?

Review examines the effects of intermittent fasting (IF) on the human gut microbiome, revealing variable impacts on microbiota composition and diversity, influenced by fasting type, dietary habits, and individual microbiome characteristics.

14 Feb 2024

Smoking, infection, and BMI found to significantly sway immune response, study shows

Study reveals how smoking, CMV latent infection, and BMI significantly influence cytokine release, impacting immune response variability and potentially affecting disease risk.

14 Feb 2024

Antiseptic mouthwash reduces periodontitis bacteria in diabetes patients

More than bad breath, there is growing evidence that ongoing inflammation in the mouth, like with gum disease, is associated with serious diseases such as Alzheimer's disease or type 2 diabetes.

14 Feb 2024

Microgreens: Superfoods for the future, packed with nutrients and easy to grow

Review in Heliyon highlights the nutritional superiority, cultivation methods, and health benefits of microgreens, emphasizing their potential as a sustainable functional food amidst global health and environmental challenges.

12 Feb 2024

Gene editing gets a boost with new CRISPR-COPIES

CRISPR/Cas systems have undergone tremendous advancement in the past decade. These precise genome editing tools have applications ranging from transgenic crop development to gene therapy and beyond.

12 Feb 2024

Pregnant women show significant immune system changes linked to gut microbiome

How gut microbiota and metabolite changes relate to immune function during pregnancy.

12 Feb 2024

CDC releases new syphilis testing guidelines to combat rising cases

The CDC's new guidelines in the Morbidity and Mortality Weekly Report outline comprehensive testing protocols for syphilis diagnosis, emphasizing the combined use of nontreponemal and treponemal tests to improve detection and management of the disease in the U.S.

11 Feb 2024

Reducing diabetes medication costs can be one step toward improving health outcomes

A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that reducing out-of-pocket costs for patients with diabetes, especially those considered low income, can be one step toward improving health outcomes.

9 Feb 2024

LSHTM researchers receive £2m funding to develop novel vaccines, diagnostics and therapeutics

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2m funding through the UK Research and Innovation's (UKRI) Technology Missions Fund, to develop novel vaccines, diagnostics and therapeutics.

9 Feb 2024

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen that causes gonorrhea, Neisseria gonorrhoeae (NG), and its susceptibility to ciprofloxacin, a former frontline oral antibiotic that can no longer treat resistant NG.

9 Feb 2024